# Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico: Not applicable (device, behavioral) study in Acute Myeloid Leukemia (420 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico |
| Sponsor type | Academic and hospital |
| Study | This Study Aims to Improve the Stratification of Patients With Acute Myeloid Leukemia to Enable More Personalized and Effective Treatments, and to Identify and Functionally Validate, at the Single-cell Level, Biomarkers That Can Predict Response to Venetoclax. |
| NCT ID | NCT07874100 |
| Phase | Not applicable (device, behavioral) |
| Status | recruiting |
| Conditions | Acute Myeloid Leukemia |
| Intervention types | genetic |
| Target enrollment | 420 |
| Site countries | Italy |
| Posted | 2026-10-14 |
| Planned start | 2022-05-10 |
| Event | Newly registered study |
| Event date | 2026-10-14 |

## Why this score
- 420 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07874100). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.